Showing results (201-210 of 1,394) with videos related to
Sort By:
Pageof 140
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1989
Topical BVDU plus low-dosage steroids in the treatment of chronic relapsing zoster keratouveitis. A pilot studyC Ameye, R Sundmacher, E de ClercqAntiviral Research|May 1, 1989
Potentiating effect of ribavirin on the anti-retrovirus activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside in vitro and in vivoJ Balzarini, P Herdewijn, E De ClercqBiochemical Pharmacology|June 15, 1989
(E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activityR Bernaerts, C Desgranges, E De ClercqBiochemical Pharmacology|June 1, 1989
Homocysteine potentiates the antiviral and cytostatic activity of those nucleoside analogues that are targeted at S-adenosylhomocysteine hydrolaseE De Clercq, M Cools, J BalzariniAntimicrobial Agents and Chemotherapy|February 1, 1989
Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivoE De Clercq, A Holý, I RosenbergEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1996
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitroR Snoeck, G Andrei, E De ClercqGene Therapy|October 6, 2000
Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV)B Degrève, E De Clercq, J BalzariniEuropean Journal of Biochemistry|April 28, 2000
Fidelity analysis of HIV-1 reverse transcriptase mutants with an altered amino-acid sequence at residues Leu74, Glu89, Tyr115, Tyr183 and Met184H Jonckheere, E De Clercq, J AnnéJournal of Viral Hepatitis|March 16, 2000
Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell cultureC Ying, E De Clercq, J NeytsMedicinal Research Reviews|March 21, 2000
The HIV-1 reverse transcription (RT) process as target for RT inhibitorsH Jonckheere, J Anné, E De ClercqPageof 140